Longer term readers will recall that Ex-CEO Fred Hassan told us -- pre-bust-up -- that increased Russian sales would offset the drop in Vytorin revenue post ENHANCE. Remember? Sure you do. [What a load of vodka potatoes that was! It would have required that one in every seven Roubles spent on drugs in Russia, be spent on Schering-Plough products, even though Schering was then only the tenth largest pharma concern in Russia!] Well, the Russian revenue machine is likewise departing, per a Russian press report:
. . . .In the biopharma industry since 1982, van Bijleveld most recently was General Manager and Vice President, Russian Federation, for Schering Plough, leading substantial growth for the commercial business in the market. Prior to Schering Plough, he held several leadership positions with Organon, including: General Manager, Organon Netherlands; Vice President, Latin America, Middle East and Africa; Sales and Marketing Director Latin America and General Manager Andina; and other leadership positions around the globe. . . .
What a tangled weave, that once was. . . . Carry on.
No comments:
Post a Comment